Free tools Windows power users keep installed
One-click scans. No signup required.
Manulife’s long-term care (LTC) reinsurance transaction with Munich Re Life US closed on October 1, 2026, and has an effective date of July 1, 2026. The C$3.2 billion figure refers to IFRS reserves covered at an 80% quota share—not a cash purchase price. The agreement transfers biometric risk on a standalone block of Manulife LTC policies; Manulife says no assets transferred.
What closed, and when?
Manulife announced the agreement on August 5, 2026, with closing then expected in the fourth quarter, subject to regulatory approvals. Its October 1 notice confirmed that the transaction had closed and specified July 1, 2026, as its effective date. The closing notice supersedes the earlier expected-closing status.
The counterparty is Munich American Reassurance Company, also identified as Munich Re Life US and described by Manulife as a Munich Re Group subsidiary. The transaction is an agreement between insurers, not a change to an individual consumer’s LTC insurance purchase.
What does the C$3.2 billion figure mean?
Manulife reported C$3.2 billion of IFRS reserves at an 80% quota share. It defines the IFRS 17 current estimate as comprising the present value of future cash flows, a risk adjustment, and a contractual service margin. The reserve amount describes the covered business on that accounting basis; it is not a disclosed cash sale price or premium.
#1 Best Overall
Which risks and assets are involved?
Manulife said the agreement provides full risk transfer on biometric risk for the covered LTC block and that no assets would transfer. Biometric risk concerns outcomes such as claims arising from policyholders’ longevity or health-related experience. The public announcements do not disclose the complete contract terms or explain detailed operational changes, so those should not be inferred from the reserve figure or risk-transfer description.
What effects did Manulife report?
The impact estimates below were disclosed in Manulife Financial Corporation’s 2026 announcement. They are company estimates, not independently measured outcomes; the close notice confirmed completion but did not restate every estimate.
Rank #2
- Ideal for Gifting
- Ideal for a bookworm
- Compact for travelling
| Reported measure | What Manulife said | How to read it |
|---|---|---|
| LTC morbidity sensitivity | 24% cumulative reduction across its three LTC reinsurance transactions upon closing | A reduction in sensitivity, not a measured 24% decline in claims or morbidity. |
| Cede | Negative 5%, described as modest and on an IFRS basis | Manulife’s description of the transaction’s cede; the public summary does not supply full pricing terms. |
| Earnings | Approximately C$30 million first-year impact to core earnings and net income attributable to shareholders, declining over time | A forecast impact, not a realized result. Manulife identifies core earnings as a non-GAAP measure. |
Manulife said its quoted figures and estimates were based on June 30, 2026 positions unless stated otherwise.
How this fits Manulife’s earlier LTC reinsurance deals
Manulife called the Munich Re agreement its third LTC reinsurance transaction in under three years and its first on a standalone LTC block. Its comparison gives the following figures for the earlier transactions:
| Transaction | Reported scope and amount | Announcement | Closing |
|---|---|---|---|
| Global Atlantic | $13 billion transaction, including $6 billion of LTC | December 2023 | February 2024 |
| RGA | $5.4 billion transaction, including $2.4 billion of LTC | November 2024 | January 2025 |
Those figures describe the transactions as Manulife presented them; the public comparison does not establish that their scopes, reserve bases, quota shares, asset treatment, or earnings effects match the Munich Re agreement.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the announcement does not establish
The public releases do not state the number of policies in the block, provide the full reinsurance contract, quantify Munich Re’s expected return, or detail policyholder servicing changes. The reserve figure is not a basis for estimating policy count or the amount Munich Re paid.
Rank #4
Manulife CEO Phil Witherington characterized the transaction as a way to reduce risk and strengthen the business. That is management’s explanation of its strategy, rather than an independent assessment of the transaction’s merits.
Quick Recap
Best Value
- It can be a gift option
- Comes with secure packaging
- Helpful in various ways
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
Recommended Free Tools
